{
    "2020-04-23": [
        [
            {
                "time": "2021-03-02",
                "original_text": "Johnson & Johnson Announces Collaboration to Expand Manufacturing Capabilities For its COVID-19 Vaccine Candidate in Support of the Company's Goal to Supply More Than One Billion Vaccine Doses Globally",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "COVID-19",
                        "Vaccine",
                        "Manufacturing",
                        "Collaboration"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-04-23",
                "original_text": "21% tested positive for coronavirus antibodies in NYC, Cuomo says",
                "features": {
                    "keywords": [
                        "21%",
                        "antibodies",
                        "coronavirus",
                        "NYC",
                        "Cuomo"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-05-10",
                "original_text": "Johnson & Johnson: Full Recovery in Sight",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Recovery"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-04-29",
                "original_text": "Is ISRG Stock A Buy After Coronavirus Slammed Quarterly Growth?",
                "features": {
                    "keywords": [
                        "ISRG",
                        "Stock",
                        "Coronavirus",
                        "Quarterly Growth"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "technology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-05-08",
                "original_text": "The Daily Biotech Pulse: FDA Nod For Immunomedics, Lilly's Solid Q1 Beat, Predictive Oncology Restructures Debt",
                "features": {
                    "keywords": [
                        "FDA",
                        "Immunomedics",
                        "Lilly",
                        "Q1 Beat",
                        "Predictive Oncology",
                        "Debt Restructures"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}